Geneoscopy
PrivateLast Round
Series C
Jan 8, 2025
Total Funding Raised
$218.4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Geneoscopy is a life sciences company that develops noninvasive diagnostic tests for gastrointestinal health, including colorectal cancer screening.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B2C
Customer Profile
Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Geneoscopy Comparables
Compare Geneoscopy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellMax Life | 83% | |
| Quantum Cyber N.V. | 82% | |
| Universal Diagnostics | 82% |
Geneoscopy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 8, 2025 | ||||
| Series B | Nov 16, 2021 | ||||
| Debt | Nov 16, 2021 | ||||
| Series A | Oct 2, 2019 | ||||
| Seed | Apr 1, 2018 | ||||
Grant | Oct 23, 2017 |
Key People
Founding team and executive leadership
Geneoscopy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovatus Capital Partners | Debt, Series B |
| NT Investments | Debt, Series C, Series B, Series A |
| Petrichor Healthcare Capital Management | Series C |
| Granger Management | Series C |
| Arch Grants | Grant, Seed |
| NT Investment Group | Series C |
| Cultivation Capital | Debt, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 64% MoM, reaching 4.1K.
- Jul 27, 2026
Grew 18% QoQ, from 61 to 72 employees.
Geneoscopy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Geneoscopy's valuation, stock price, and market status.
Is Geneoscopy a public or private company?
Geneoscopy is a private company.
What is the current stock price of Geneoscopy?
Geneoscopy is a private company with no public stock price. No recent secondary market data is available.
How much is Geneoscopy worth (valuation)?
Valuation information for Geneoscopy is not publicly available.
Can I buy Geneoscopy stock?
Geneoscopy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Geneoscopy's last funding round?
Geneoscopy's most recent funding round was Series C on January 8, 2025.
Who are the main investors in Geneoscopy?
Key investors in Geneoscopy include NT Investments, Cultivation Capital, LightChain Capital.
Will Geneoscopy IPO soon?
No public IPO plans have been announced for Geneoscopy.
How can I track Geneoscopy secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Geneoscopy's secondary market activity and sign up for updates.